Advancing the Next Era of Medical Affairs
Today's Medical Affairs leaders must balance scientific credibility, stakeholder engagement, evidence generation, and cross-functional collaboration in an increasingly complex healthcare environment. Fierce Pharma Week brings together Medical Affairs, commercial, marketing, and communications leaders to share insights, align strategies, and advance organizational success across the product lifecycle.
See Who's Already Registered...
Here's a small sample of attendees already registered from the Medical Affairs Community for 2026!
National Field Director, AbbVie
Global Integrated Medical Communications Pillar Lead, Boehringer Ingelheim
Market Access National Account Director, Genmab
Executive Director Global Medical Affairs Lead, Mirum Pharmaceuticals
VP Medical Affairs Channel Excellence and Medical Digital Health Solutions, Pfizer
Vice President Global Medical Communications and Operations, Taiho Oncology
Franchise Head Gyne/GU Cancer US Medical Affairs, AstraZeneca
SVP Head of Cell Therapy Medical Affairs, Bristol Myers Squibb
Senior Director Medical Communications Neuroscience Franchise, Jazz Pharmaceuticals
Chief Medical Officer, Ovid Therapeutics
Head of Field Medical Excellence, Pfizer
CMO and Head of Global Medical Affairs Global Oncology Business Unit, Takeda
Medical Communications Excellence, BMS
Director Communication & Publication GSMA, Daiichi Sankyo Inc.
SVP Global Medical Affairs, KalVista Pharmaceuticals
Chief Medical Officer, PDS Biotechnology
Senior Medical Director T1D Immunology, Sanofi
Head of Real World Evidence and Outcomes Research, Viatris
Global Head Medical Affairs Excellence, Boehringer Ingelheim
Head- Omnichannel Medical Engagement, Genentech
Executive Director RWE Operations, Merck
Chief Medical Affairs Officer of Medical Engagements & Impact, Pfizer
Chief Medical Officer, SynOx Therapeutics
SVP Medical Affairs, Xilio Therapeutics
The Ideas, Strategies & Trends Defining Medical Affairs
Dive into three specialized tracks designed to help navigate today's biggest challenges and opportunities.
Medical Affairs Strategy
Explore how Medical Affairs is driving strategic impact across the healthcare ecosystem.
Medical Communications
Deliver clear, credible, and engaging scientific communications that inform and inspire action.
Field Medical
Strengthen thought leader engagement and scientific exchange through high-impact field strategies.
The Leaders Advancing Medical Affairs
Learn from the executives, innovators, and changemakers shaping the future of scientific engagement, medical strategy, and organizational impact.
The Strategies Shaping Medical Affairs
Explore the sessions tackling today's most important Medical Affairs challenges, opportunities, and innovations.
Key Topics in the Medical Affairs Community:
Evolve Medical Affairs Leadership to Navigate a Changing Healthcare Landscape
Develop an Integrated Omnichannel Strategy to Enhance HCP Engagement
Leverage MSL Insights to Drive Clinical and Commercial Strategy Alignment
Maximize Stakeholder Engagement by Balancing Digital and Face-to-Face Interactions
Harness AI and Data to Optimize Medical Affairs Decision-Making and Strategy
Utilize Digital Tools to Strengthen MSL Field Engagement and Knowledge Sharing
Your pass unlocks every community—Marketing, PR, Medical Affairs & Commercialization.
Uniting the Pharma Community
Connect with 3,000+ life science executives – 72% Director level or above.
Fierce Pharma Week is the must-attend conference for life sciences executives and leaders, uniting four essential communities who drive integrated go-to-market strategies across marketing, sales, scientific communications & medical affairs, new product planning & commercial development, and PR & communications.
As the most integrated gathering of pharma and biotech leaders, partners have the unique opportunity to Educate, Network, Drive Unique Experiences to Elevate their brands where it matters most.
Let's work together!
Find out why Fierce Pharma Week is the ultimate networking opportunity to reach key decision makers across every corner of the biopharma ecosystem.